Asarez, Baby Girl .

HRN: 26-18-65  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2024
AMPICILLIN 250MG (VIAL)
11/08/2024
11/15/2024
INTRAVENOUS
90 Mg IVTT
Every 12 Hours
Sepsis Neonatorum
Waiting Final Action 
11/08/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
11/08/2024
11/15/2024
INTRAVENOUS
9 Mg
Every 24 Hours
Sepsis Neonatorum
Waiting Final Action 
11/13/2024
CEFOTAXIME 500MG (VIAL)
11/13/2024
11/20/2024
IV
100 Mg
Q12 Hrs
Sepsis Neonatorum
Waiting Final Action 
11/16/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/16/2024
11/22/2024
IV
130mg
Q8h
Sepsis Neonatorum
Waiting Final Action 
11/24/2024
FLUCONAZOLE 50MG (CAP)
11/24/2024
12/08/2024
PO
11mg/pptab As LD Then 6ml
Q24H
Sepsis
Waiting Final Action 
11/24/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
11/24/2024
12/01/2024
TOPICAL
0.3ml
TID
Mouth Ulcers
Waiting Final Action 
11/24/2024
MUPIROCIN 2%, 15G (TUBE)
11/24/2024
12/01/2024
TOPICAL
Pea-sized
BID
Phlebitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: